JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
The RCSed's Court of Regents comprises a group of distinguished and accomplished individuals in their field
The company will develop and produce premixes for human nutrition applications
The state-of-the-art digital PETCT imaging system, highlights a significant advancement in the fight against cancer and detects other lesions offering patient centric services
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
Subscribe To Our Newsletter & Stay Updated